Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 75GZ7 | IM / RA |
Allergic reaction; Lethargic; Could not get up; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of allergic reaction in a elderly male patient who received Herpes zoster (Shingrix) (batch number 75GZ7) for prophylaxis. Concurrent medical conditions included parkinson's disease. On 14-MAY-2025, the patient received the 2nd dose of Shingrix (intramuscular, right arm). In MAY-2025, less than a week after receiving Shingrix, the patient experienced allergic reaction (Verbatim: Allergic reaction), lethargy (Verbatim: Lethargic) and mobility decreased (Verbatim: Could not get up). The outcome of the allergic reaction, lethargy and mobility decreased were resolving. The reporter considered the allergic reaction, lethargy and mobility decreased to be related to Shingrix. The company considered the allergic reaction, lethargy and mobility decreased to be related to Shingrix. Additional Information: GSK Receipt Date: 16-MAY-2025 The reporter is a pharmacist called to report that the wife of a male patient stated that the patient had an allergic reaction, got lethargic, and could not get up (no specific date provided). The patient was taken to the emergency room, was checked at the emergency room, and was discharged (no specific date provided). The reporter did not know if the patient had an overnight stay at the Emergency Room. The patient was told at the emergency room that he was experiencing side effects from receiving the second dose of Shingrix. The patient was now back home and doing okay. The reporter had notified the patient's physician, and provided consent to follow up with the patient's physician. The reporter stated that they do not fill the patient's prescription medications, and he had no prescription history to provide.
Parkinson's disease